Reply by Authors
J Urol
.
2021 Oct;206(4):923.
doi: 10.1097/JU.0000000000001841.03.
Epub 2021 Jul 23.
Authors
Neeraj Agarwal
1
,
Kelly McQuarrie
2
,
Anders Bjartell
3
,
Simon Chowdhury
4
,
Andrea J Pereira de Santana Gomes
5
,
Byung Ha Chung
6
,
Mustafa Özgüroğlu
7
,
Álvaro Juárez Soto
8
,
Axel S Merseburger
9
,
Hirotsugu Uemura
10
,
Dingwei Ye
11
,
Robert Given
12
,
Ethan Basch
13
,
Branko Miladinovic
14
,
Angela Lopez-Gitlitz
15
,
Kim N Chi
16
Affiliations
1
Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah.
2
Janssen Research & Development, Horsham, Pennsylvania.
3
Skåne University Hospital, Lund University, Malmö, Sweden.
4
Guy's, King's, and St Thomas' Hospitals, and Sarah Cannon Research Institute, London, United Kingdom.
5
Liga Norte Riograndense Contra O Câncer, Natal, Brazil.
6
Yonsei University College of Medicine and Gangnam Severance Hospital, Seoul, South Korea.
7
Istanbul University-Cerrahpaşa, Cerrahpaşa School of Medicine, Istanbul, Turkey.
8
Hospital Universitario de Jerez de la Frontera, Cadiz, Spain.
9
University Hospital Schleswig-Holstein, Campus Lübeck, Lübeck, Germany.
10
Kindai University Faculty of Medicine, Osaka, Japan.
11
Fudan University Shanghai Cancer Center, Shanghai, China.
12
Urology of Virginia, Eastern Virginia Medical School, Norfolk, Virginia.
13
University of North Carolina, Chapel Hill, North Carolina.
14
Janssen Research & Development, San Diego, California.
15
Janssen Research & Development, Los Angeles, California.
16
BC Cancer, Vancouver, British Columbia, Canada.
PMID:
34296946
DOI:
10.1097/JU.0000000000001841.03
No abstract available
Publication types
Comment